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More than 100 years of investigation have found that
seizures and migraine co-occur in some affected indivi-
duals and families, and there is much evidence that
these diseases share genetic susceptibility. In particular,
in a recent review, the prevalence of migraine in epilep-
tic patients was about 12% [1]. On the other hand, epi-
lepsy exhibits a prevalence of about 6% in migraineurs
[2]. Moreover, epilepsy has also been reported in
patients with familial hemiplegic migraine (FHM).
Although few studies showed a prevalence of epilepsy of
about 7% in FHM, currently no conclusive data are
available.
Certainly, epilepsy and migraine share common char-
acteristics that the underlying pathophysiology relates to
alterations in ion channels or ion transporters. In these
episodic functional diseases, in which susceptible brain
regions are hyperexcitable, the attacks begin with hyper-
synchronous neuronal firing [3]. In epilepsy, a-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptors play a predominant role in mediating the gen-
eration and spread of seizure activity whereas in
migraine mainly N-methyl-D-aspartate (NMDA) recep-
tors are involved in triggering CSD. However, the nature
of the ionic conductance changes leading to the massive
but transitory neuronal depolarization underlying CSD
has not yet been define [4].
Genetically determined dysfunction of ion transporters
seems to point at a common underlying mechanism for
both paroxysmal disorders. In the last two decades the
mutations in the ion transportation genes CACNA1A,
ATP1A2 and SCN1A have been identified for FHM. Con-
versely, only a few CACNA1A and ATP1A2 mutations
have been reported in patients with sporadic hemiplegic
migraine (SHM). These cases can be caused by a de novo
mutation or by inheritance of a gene mutation from
asymptomatic carrier and are usually characterized by
early-onset, severe and complex disorders.
Certainly, genetic analysis can provide greater insight
into the potential causes of both disorders and it could
contribute to better treatment choices.
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